CO
Income statement / Annual
Last year (2022), Global Cord Blood Corporation's total revenue was $1.24 B,
an increase of 7.21% from the previous year.
In 2022, Global Cord Blood Corporation's net income was $501.07 M.
See Global Cord Blood Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
03/31/2014 |
03/31/2013 |
| Operating Revenue |
$1.24 B
|
$1.16 B
|
$1.22 B
|
$986.75 M
|
$936.77 M
|
$759.98 M
|
$663.00 M
|
$635.12 M
|
$572.86 M
|
$526.12 M
|
| Cost of Revenue |
$183.31 M |
$178.95 M |
$189.13 M |
$186.03 M |
$181.48 M |
$142.64 M |
$144.60 M |
$130.61 M |
$106.23 M |
$106.62 M |
| Gross Profit |
$1.06 B |
$980.69 M |
$1.03 B |
$800.73 M |
$755.29 M |
$617.34 M |
$518.40 M |
$504.51 M |
$466.63 M |
$419.50 M |
| Gross Profit Ratio |
0.85 |
0.85 |
0.85 |
0.81 |
0.81 |
0.81 |
0.78 |
0.79 |
0.81 |
0.8 |
| Research and Development
Expenses |
$22.30 M
|
$23.77 M
|
$21.11 M
|
$14.69 M
|
$12.72 M
|
$10.37 M
|
$8.96 M
|
$9.91 M
|
$9.77 M
|
$8.46 M
|
| General & Administrative
Expenses |
$187.06 M
|
$174.36 M
|
$190.23 M
|
$169.32 M
|
$243.50 M
|
$189.94 M
|
$169.95 M
|
$131.68 M
|
$112.24 M
|
$108.05 M
|
| Selling & Marketing
Expenses |
$241.73 M
|
$237.69 M
|
$261.96 M
|
$235.06 M
|
$219.20 M
|
$178.48 M
|
$148.16 M
|
$127.93 M
|
$112.69 M
|
$93.68 M
|
| Selling, General &
Administrative Expenses |
$428.79 M
|
$412.05 M
|
$452.19 M
|
$404.38 M
|
$462.70 M
|
$368.42 M
|
$318.11 M
|
$259.61 M
|
$224.93 M
|
$201.73 M
|
| Other Expenses |
$6.27 M |
$8.16 M |
$7.39 M |
$5.70 M |
$4.23 M |
$5.97 M |
-$113,000.00 |
$861,000.00 |
$2.21 M |
$203,000.00 |
| Operating Expenses |
$451.08 M |
$435.82 M |
$473.30 M |
$419.07 M |
$475.42 M |
$352.47 M |
$327.07 M |
$269.52 M |
$234.71 M |
$210.19 M |
| Cost And Expenses |
$634.39 M |
$614.77 M |
$662.43 M |
$605.10 M |
$656.91 M |
$495.11 M |
$471.67 M |
$400.13 M |
$340.93 M |
$316.81 M |
| Interest Income |
$32.61 M |
$30.90 M |
$25.36 M |
$25.32 M |
$21.94 M |
$17.42 M |
$18.22 M |
$18.25 M |
$16.87 M |
$15.06 M |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$3.26 M |
$119.42 M |
$107.97 M |
$101.10 M |
$70.08 M |
$70.10 M |
| Depreciation &
Amortization |
$19.91 M
|
-$26.82 M
|
$12.97 M
|
$52.37 M
|
$50.59 M
|
$50.48 M
|
$50.17 M
|
$50.61 M
|
$37.07 M
|
$35.87 M
|
| EBITDA |
$628.78 M
|
$518.05 M
|
$572.00 M
|
$404.75 M
|
$353.60 M
|
$333.71 M
|
$299.10 M
|
$306.33 M
|
$297.44 M
|
$256.96 M
|
| EBITDA Ratio |
0.51 |
0.45 |
0.47 |
0.41 |
0.38 |
0.44 |
0.45 |
0.48 |
0.52 |
0.49 |
| Operating Income Ratio
|
0.49
|
0.47
|
0.46
|
0.39
|
0.3
|
0.35
|
0.29
|
0.37
|
0.4
|
0.4
|
| Total Other
Income/Expenses Net |
$18.97 M
|
$65.88 M
|
$19.78 M
|
-$25.20 M
|
$23.67 M
|
-$98.55 M
|
-$50.00 M
|
-$79.88 M
|
-$41.00 M
|
-$51.13 M
|
| Income Before Tax |
$627.84 M |
$610.75 M |
$578.81 M |
$356.46 M |
$303.54 M |
$166.31 M |
$141.33 M |
$155.12 M |
$190.92 M |
$158.19 M |
| Income Before Tax Ratio
|
0.5
|
0.53
|
0.47
|
0.36
|
0.32
|
0.22
|
0.21
|
0.24
|
0.33
|
0.3
|
| Income Tax Expense |
$118.35 M |
$94.55 M |
$101.08 M |
$61.26 M |
$62.66 M |
$37.62 M |
$50.00 M |
$47.33 M |
$58.40 M |
$38.54 M |
| Net Income |
$501.07 M |
$508.25 M |
$470.72 M |
$291.12 M |
$237.10 M |
$126.19 M |
$90.97 M |
$107.29 M |
$131.90 M |
$112.45 M |
| Net Income Ratio |
0.4 |
0.44 |
0.39 |
0.3 |
0.25 |
0.17 |
0.14 |
0.17 |
0.23 |
0.21 |
| EPS |
4.12 |
4.18 |
3.87 |
2.4 |
1.99 |
1.59 |
1.25 |
1.36 |
1.6 |
1.49 |
| EPS Diluted |
4.12 |
4.18 |
3.87 |
2.4 |
1.99 |
1.59 |
1.25 |
1.36 |
1.6 |
1.49 |
| Weighted Average Shares
Out |
$121.55 M
|
$121.55 M
|
$121.55 M
|
$121.30 M
|
$119.14 M
|
$79.36 M
|
$72.78 M
|
$78.89 M
|
$82.44 M
|
$75.47 M
|
| Weighted Average Shares
Out Diluted |
$121.55 M
|
$121.55 M
|
$121.55 M
|
$121.30 M
|
$119.14 M
|
$79.36 M
|
$72.78 M
|
$78.89 M
|
$82.44 M
|
$75.47 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
